Sol Endocrinology points Dallas diabetes patients to free Stanford tool

Sol Endocrinology in Dallas is directing patients using insulin pumps, CGMs and automated insulin delivery systems to DiabetesWise, a free Stanford-built website that helps people compare diabetes technology. The practice says the tool can help patients narrow options before visits and make coverage discussions more productive.

Why it matters: - Diabetes technology choices now affect daily routines, comfort and costs for many patients with diabetes. - A better match between device and lifestyle can improve use, follow-through and care planning. - Sol Endocrinology is trying to make device selection more practical by pairing clinical care with a free decision tool.

What happened: - Sol Endocrinology, led by Dr. Erin Roe, is guiding patients to DiabetesWise, a free, independent website developed by Stanford University researchers. - The Dallas practice is directing patients on insulin pumps, CGMs and automated insulin delivery systems to the resource. - Dr. Roe said, “There isn’t one right device for everyone — there’s a right device for each patient.” - Dr. Roe said DiabetesWise gives patients a judgment-free way to think through options before an office visit.

The details: - DiabetesWise walks users through a short guided check-in. - The site offers plain-language profiles of major device categories. - It includes first-person videos from people with diabetes describing why a device worked or did not work for them. - The tool helps patients think through insurance and Medicare coverage. - The site prepares a personalized summary for the next appointment. - Sol Endocrinology says clinical evidence and personal fit both matter in diabetes technology decisions. - For type 1 diabetes, automated insulin delivery systems generally produce better glucose outcomes than a pump or injections alone, and CGM use is now considered standard of care. - For type 2 diabetes, CGM has been shown to improve A1C for many patients, including some not using insulin. - Several automated insulin delivery systems are now approved for type 2 use. - Coverage and eligibility still vary by insurance plan, and the practice works with patients to confirm what each plan allows. - Patients are encouraged to complete the free 10–15 minute check-in at diabeteswise.org before their next visit. - Patients are also asked to note top device options and concerns and bring that list to an appointment for coverage review and, when appropriate, hands-on training.

Between the lines: - The push reflects a broader shift in diabetes care from one-size-fits-all treatment to more personalized technology decisions. - Insurance rules remain a major part of the decision, so the tool is meant to save time before patients reach the clinic. - The practice is using the website to help patients arrive with more specific questions and expectations.

What's next: - Sol Endocrinology wants patients to use the tool before their next visit. - The practice will review device options and coverage during appointments. - Hands-on training may follow when a device choice is a fit.

The bottom line: - Sol Endocrinology is betting that a free Stanford-built tool can help Dallas patients choose diabetes technology that fits both their medical needs and their lives.